Scope
Reference
C382504
Description
Project title: NHS National Framework for Omalizumab commencing 1st February 2026
Offer reference number: CM/TNS/25/5734
Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Commercial tool
Establishes a framework
Total value (estimated)
- £125,417,000 excluding VAT
- £150,500,400 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 February 2026 to 31 August 2027
- Possible extension to 31 August 2029
- 3 years, 7 months
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKJ - South East (England)
- UKK - South West (England)
Engagement
Engagement deadline
18 September 2025
Engagement process description
NHS England is seeking to engage with suppliers that are planning to launch Omalizumab injection. Interested suppliers will be invited to a virtual PME meeting to be held on Thursday 18th September 2025
The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.
Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
1 October 2025
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Region: UKI45 - Lambeth
Organisation type: Public authority - central government